#United States #Prolacta Bioscience #Duarte #Human Milk #NEC

Exclusive Human Milk Diet Significantly Reduces NEC Risk in Premature Infants

Recent findings from a pivotal systematic review and meta-analysis published in Nutrients shed light on the importance of diet in the health of premature infants. This extensive study examined data from 20 different studies, involving 6,794 very low birth weight (VLBW) infants, revealing that an Exclusive Human Milk Diet (EHMD) fortified with human milk-based products can dramatically lower the risk of necrotizing enterocolitis (NEC). The analysis indicated a 35% reduction in medical NEC and an impressive 49% decrease in surgical NEC compared to diets that include cow milk-based products.

Understanding NEC and Its Impact

Necrotizing enterocolitis is a severe intestinal condition that primarily affects premature infants, leading to significant mortality and disability rates within this vulnerable population. The recent findings are particularly important for healthcare professionals and families making nutrition choices for these at-risk infants. Dr. Jenelle Ferry, a neonatologist and co-author of the study, emphasizes the protective benefits of human milk-based diets, resonating with her observations in clinical practice.

Analyzing the Findings

The meta-analysis included rigorous assessments from both randomized controlled trials and observational cohort studies conducted across multiple countries including the United States, Canada, and several European nations. Researchers utilized advanced statistical methods to ensure equitable comparisons despite variations in study design and patient characteristics.

Despite previous randomized trials yielding inconsistent results due to limited sample sizes, this comprehensive synthesis showcases a consistent pattern of benefits across all examined studies. The data suggest that for VLBW infants, especially those weighing 1,250 grams or less, an EHMD with human milk-based fortifiers is associated with significant reductions in both medical and surgical forms of NEC.

Types of NEC

Medical NEC is characterized by less severe, yet still critical, symptoms that require immediate interventions such as stopping feedings and administering antibiotics. On the other hand, surgical NEC is the more intense form, often life-threatening, requiring surgical intervention when the intestinal tissue is damaged or perforated. This stark difference in severity underlines the findings’ implications on infant health outcomes.

Key Takeaways from the Study

1. Type of Fortifier Matters: The study found that using Prolacta's human milk-based fortifiers led to improved outcomes compared to cow milk-derived alternatives.
2. Statistical Significance Across Studies: Both randomized controlled trials and observational studies demonstrated significant protective benefits, affirming the robustness of the EHMD.
3. Focus on the Most Vulnerable: A majority of the infants included in this analysis were extremely low birth weight, emphasizing the heightened risk they face from NEC.

Researchers have called for enhanced standardization in fortification protocols, suggesting that future trials focus on large, pragmatic registries to document real-world feeding practices and their outcomes. Traditional randomized trials face challenges in scalability and practicality, given the high numbers needed for conclusive results.

Prolacta Bioscience's Commitment

Prolacta Bioscience stands at the forefront of this essential research, harnessing the science behind human milk to enhance health outcomes for critically ill and premature infants. Since its inception, the company has provided human milk-based nutritional products that have positively impacted over 125,000 extremely premature infants worldwide. Their innovative approaches, like Surgifort®—the only FDA-approved human milk-based fortifier designed for term infants post-surgery—represent significant advancements in neonatal care.

In conclusion, the insights from this comprehensive analysis provide a critical foundation for future nutritional strategies aimed at improving the health and survival of vulnerable infants in neonatal intensive care settings. By prioritizing human milk diets, healthcare providers can potentially improve clinical outcomes and enhance the quality of care delivered to these fragile patients.